Multi-institution case-control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan
- PMID: 25186155
- PMCID: PMC4158213
- DOI: 10.1136/bmjopen-2014-005665
Multi-institution case-control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan
Abstract
Objective: To examine risk factors for Clostridium difficile infection (CDI) morbidity and mortality in Japan.
Design: Multimethod investigation including a case-control study and cohort study.
Setting: 47 participating facilities of the National Hospital Organization (NHO).
Participants: 1026 patients with CDI and 878 patients in the control group over the age of 18 years admitted to the subject NHO facilities from November 2010 to October 2011.
Main outcome measures: In a case-control study, we identify risk factors for CDI development. Next, in a cohort study, we identify risk factors for all-cause mortality within 30 days following CDI onset.
Results: A total of 1026 cases of CDI meeting the definitions of this investigation were identified, encompassing 878 patients at 42 of the 47 subject facilities. In the case-control study, we identified, compared with no antibiotics use, use of first-generation and second-generation cephem antibiotics (OR 1.44; 95% CI 1.10 to 1.87), use of third-generation and fourth-generation cephem antibiotics (OR 1.86; 95% CI 1.48 to 2.33) and use of carbapenem antibiotics (OR 1.87; 95% CI 1.44 to 2.42) the risk factors for CDI development. However, use of penicillin was not identified as a risk factor. In the cohort study, sufficient data for analysis was available for 924 CDI cases; 102 of them (11.0%) resulted in death within 30 days of CDI onset. Compared with no anti-CDI drug use, use of vancomycin was associated with reduced risk of mortality (OR 0.43; 95% CI 0.25 to 0.75) whereas metronidazole was not.
Conclusions: The findings mirror those of previous studies from Europe and North America, identifying the administration of broad-spectrum antibiotics as a risk factor for CDI development. The use of vancomycin is associated with a decreased risk of mortality.
Keywords: EPIDEMIOLOGY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures
References
-
- Honda H, Yamazaki A, Sato Y, et al. Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center. Anaerobe 2014;25:5–10 - PubMed
-
- Kato H, Ito Y, van den Berg RJ, et al. First isolation of Clostridium difficile 027 in Japan. Euro Surveill 2007;12:E070111.3. - PubMed
-
- Tagashira Y, Kato H, Senoh M, et al. Two cases of fulminant colitis due to binary toxin-positive Clostridium difficile that are not PCR ribotype 027 or type 078. J Med Microbiol 2013;62:1486–9 - PubMed
-
- Sawabe E, Kato H, Osawa K, et al. Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 2007;26:695–703 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases